Two Stocks Plan Hold Next: 20-Year Hold Picks for Growth
If you’re building a retirement roadmap, long-horizon stock bets can compound your wealth. Here are two healthcare-fo...
Healthcare Stocks
This tag page curates 5 Healthcare Stocks articles to help you assess risks, dividend potential, and notable moves from Chemed to UnitedHealth, helping smarter investment decisions.
39 articles
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
What Considered Good Stock Dividends? 2 Healthcare Winners
Figuring out what considered good stock dividends means looking beyond yield. This article breaks down the metrics th...
Why a $3.5 Million Targets Avantor Bet Amid a 54% Drop
An investor group disclosed a $3.5 million stake in Avantor as the stock slipped more than half. This article breaks ...
Privia Health Group Sells: CFO Signals Tax Strategy
When a top executive unloads stock, it signals more than a simple liquidity move. This article breaks down Privia Hea...
This $6.5 Million Healthcare Move Drives Investor Signals
A notable fund trimmed a sizable healthcare stake by roughly $6.5 million as the stock soared and revenue grew. Here’...
Is Down Near 5-Year Low a Cheap Novo Nordisk Stock?
Novo Nordisk has drifted toward a five-year low, raising questions about value vs. risk. This guide breaks down the f...
Molina Healthcare Stock Falls: Is It a Buy Now?
A major fund just increased its stake in Molina Healthcare, while the stock trades lower. This guide breaks down what...
Healthcare Stock Rebound 2026: Opportunities Align
A powerful, data-driven case for why the healthcare stock rebound 2026 is more than a rumor. Learn how to spot streng...
Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
This Promising GLP-1 Drug Could Renew Novo Nordisk Hope
Novo Nordisk has faced headwinds, but a new GLP-1 drug could change the game. This article breaks down what investors...
Biotech Stock Nearly 300% Sparks Massive Bet on 2027 Breast Drug
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
Related Topics
#Investing (30)
#Stock Market (7)
#Stock Analysis (7)
#Portfolio Strategy (4)
#Novo Nordisk (4)
#Earnings Analysis (4)
#Portfolio Management (3)
#Biotech Investing (3)
#Long-Term Investing (2)
#Dividend Investing (2)
#Retirement Planning (2)
#Income Investing (2)
#Digital Health (2)
#GLP-1 (2)
#UnitedHealth (2)